Richard R. DeLuca, Jr.

Richard R. DeLuca, Jr.

Executive Vice President and President, Merck Animal HealthatMerck & Co.· In proxies 2021–2024

Pay in FY2024+47% from the year before

Richard R. DeLuca, Jr. was paid $9.1M in FY2024 (Dec), up 47%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Merck & Co. proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Merck & Co.Public company · 5 yr
    • Executive Vice President and President, Merck Animal Health2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?